End-of-day quote
Other stock markets
|
||
- CAD | - |
15/05 | Transcript : MediPharm Labs Corp., Q1 2024 Earnings Call, May 15, 2024 | |
15/05 | MediPharm Labs Q1 Gross Profit, Rise | MT |
Sales 2024 * | 4.2Cr 3.08Cr 256.86Cr | Sales 2025 * | 5.49Cr 4.03Cr 335.84Cr | Capitalization | 3.23Cr 2.37Cr 197.78Cr |
---|---|---|---|---|---|
Net income 2024 * | -90L -66.07L -55Cr | Net income 2025 * | -10L -7L -6.12Cr | EV / Sales 2024 * | 0.77 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.59 x |
P/E ratio 2024 * |
-4
x | P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.26% |
Latest transcript on Medipharm Labs Corp
Managers | Title | Age | Since |
---|---|---|---|
David Pidduck
CEO | Chief Executive Officer | - | 20/22/20 |
Greg Hunter
DFI | Director of Finance/CFO | - | 08/21/08 |
Keith Strachan
PSD | President | - | 01/18/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Bumby
BRD | Director/Board Member | 60 | 01/23/01 |
David Pidduck
CEO | Chief Executive Officer | - | 20/22/20 |
Shelley Martin
BRD | Director/Board Member | - | 22/20/22 |
1st Jan change | Capi. | |
---|---|---|
+42.38% | 627.53Cr | |
-15.86% | 451.04Cr | |
+6.36% | 334.75Cr | |
-11.28% | 313.09Cr | |
-3.23% | 247.49Cr | |
+45.24% | 195.75Cr | |
-7.89% | 168.42Cr | |
-0.98% | 163.4Cr | |
-11.32% | 156.05Cr |